Oncology medicines in Canada : (Record no. 38223)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02275cam a22005177i 4500 |
| 001 - CONTROL NUMBER | |
| control field | on1226327509 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260430103241.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d f |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cn |||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201209t20202020oncd obs f000 0 eng |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLC |
| Language of cataloging | eng |
| Description conventions | rda |
| Transcribing agency | NLC |
| Modifying agency | NLC |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER | |
| National bibliography number | 20200414615 |
| Source | can |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780660361628 |
| International Standard Book Number | 0660361620 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1226327509 |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | lac |
| 043 ## - GEOGRAPHIC AREA CODE | |
| Geographic area code | n-cn--- |
| 045 ## - TIME PERIOD OF CONTENT | |
| Time period code | y1y1 |
| 082 1# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615 |
| Edition information | 15 |
| 084 ## - OTHER CLASSIFICATION NUMBER | |
| Classification number | cci1icc |
| Number source | lacc |
| 086 1# - GOVERNMENT DOCUMENT CLASSIFICATION NUMBER | |
| Classification number | H82-51/2020E-PDF |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | NLCC |
| 245 00 - TITLE STATEMENT | |
| Title | Oncology medicines in Canada : |
| Remainder of title | trends and international comparisons, 2010-2019. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Ottawa, ON : |
| Name of producer, publisher, distributor, manufacturer | Patented Medicine Prices Review Board = Conseil d'examen du prix de médicaments brevetés, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2020. |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (32 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 500 ## - GENERAL NOTE | |
| General note | Distributed by the Government of Canada Publishing and Depository Services Program (Weekly acquisitions list 2020-49) |
| General note | Issued also in French under title: Les médicaments oncologiques au Canada : tendances et comparaisons internationales, 2010-2019. |
| General note | "October 2020." |
| General note | "NPDUIS, National Prescription Drug Utilization Information System." |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes bibliographical references. |
| 506 0# - RESTRICTIONS ON ACCESS NOTE | |
| Terms governing access | Unrestricted online access. |
| Standardized terminology for access restriction | Unrestricted online access. |
| Source of term | star |
| Institution to which field applies | CaOONL |
| 516 8# - TYPE OF COMPUTER FILE OR DATA NOTE | |
| Type of computer file or data note | Electronic monograph in PDF format. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer |
| General subdivision | Treatment |
| Geographic subdivision | Canada. |
| Topical term or geographic name entry element | Antineoplastic agents |
| Geographic subdivision | Canada. |
| Topical term or geographic name entry element | Cancer |
| General subdivision | Traitement |
| Geographic subdivision | Canada. |
| Topical term or geographic name entry element | Anticancéreux |
| Geographic subdivision | Canada. |
| 710 1# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | Canada. |
| Subordinate unit | Patented Medicine Prices Review Board, |
| Relator term | issuing body. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | Bibliothèque et Archives Canada / Library and Archives Canada |
| Uniform Resource Identifier | <a href="https://epe.lac-bac.gc.ca/100/201/301/weekly_acquisitions_list-ef/2020/20-49/publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-51-2020-eng.pdf">https://epe.lac-bac.gc.ca/100/201/301/weekly_acquisitions_list-ef/2020/20-49/publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-51-2020-eng.pdf</a> |
| Materials specified | Government of Canada Publications / Publications du gouvernement du Canada |
| Uniform Resource Identifier | <a href="http://publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-51-2020-eng.pdf">http://publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-51-2020-eng.pdf</a> |
| 994 ## - | |
| -- | C0 |
| -- | NLC |
No items available.
